iPS cells win big in poll on most clinically promising pluripotent stem cells

Pluripotent stem cell pollI just closed my blog’s poll on what are the most clinically promising pluripotent stem cells.

Why close the poll now less than 12 hours after I opened it instead of leaving the poll open longer?

You’ll find out soon enough. I can’t resist teasing you readers sometimes.

iPS cells were the big winners in the poll at 48%.

Allogeneic human ES cells were 2nd at 28%. In contrast, not a single person voted for SCNT-derived human ES cells.

Pluripotent adult stem cells finished 3rd at 20%. I found this surprising.

4% said “other”….not sure what “other” pluripotent stem cells exist.

I predict if (when) I repeat this poll soon, we’ll see a very different picture.

1 Comment

  1. I find your polling results interesting, however I noticed that there was no mention of parthenogenetic stem cells mentioned…granted this could be encapsulated under the “other” topic, but as they are a relatively new and unknown field to the “layperson” but I would have thought you would have knowledge of them to include in your poll.

2 Trackbacks / Pingbacks

  1. Penny-Wise, Pound-Foolish Stem Cell Stocks – Seeking Alpha | Stem Cell Therapies
  2. Research Uncovers Approach That May Decrease Complications of Stem Cell … – HealthCanal.com | Stem Cell Therapies

Comments are closed.